Biocure Technology Inc. (CSE:CURE.X)
Canada · Delayed Price · Currency is CAD 0.0550
0.00 (0.00%)
At close: Aug 13, 2026
Biocure Technology Balance Sheet
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 0 | 0.04 | 0.02 | 0 | 0.04 | 0.16 |
Cash & Short-Term Investments | 0 | 0.04 | 0.02 | 0 | 0.04 | 0.16 |
Cash Growth | -93.36% | 130.79% | 323.82% | -88.76% | -76.32% | 240.83% |
Other Receivables | 0.03 | 0 | 0.01 | 0.01 | 0.02 | 0.01 |
Receivables | 0.03 | 0 | 0.01 | 0.01 | 0.02 | 0.01 |
Inventory | - | - | - | - | - | 0 |
Prepaid Expenses | 0 | 0 | - | - | - | 0.07 |
Other Current Assets | - | - | - | - | 0.06 | 1.89 |
Total Current Assets | 0.03 | 0.05 | 0.03 | 0.01 | 0.12 | 2.13 |
Property, Plant & Equipment | - | - | - | - | - | 0.01 |
Long-Term Investments | 0 | 1.97 | 1.97 | 1.97 | 1.97 | 1.97 |
Other Intangible Assets | - | - | - | - | - | 0 |
Other Long-Term Assets | - | - | - | - | - | 0.04 |
Total Assets | 0.03 | 2.01 | 1.99 | 1.98 | 2.08 | 4.15 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 0.62 | 0.35 | 0.58 | 0.33 | 0.71 | 0.85 |
Accrued Expenses | - | 0.03 | 0.03 | - | - | 0.36 |
Short-Term Debt | 0.06 | - | - | - | 0.05 | 1.2 |
Current Portion of Long-Term Debt | - | 0.06 | - | - | 0.03 | 1.33 |
Current Portion of Leases | - | - | - | - | - | 0 |
Other Current Liabilities | - | - | - | - | 3.62 | - |
Total Current Liabilities | 0.68 | 0.44 | 0.6 | 0.33 | 4.41 | 3.75 |
Long-Term Debt | - | - | 0.05 | 0.04 | - | 1.25 |
Total Liabilities | 0.68 | 0.44 | 0.65 | 0.37 | 4.41 | 5.01 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 18.01 | 18.01 | 17.68 | 17.68 | 18.45 | 18.38 |
Retained Earnings | -26.16 | -23.94 | -23.83 | -23.57 | -27.5 | -26.08 |
Comprehensive Income & Other | 7.5 | 7.5 | 7.5 | 7.5 | 7.08 | 7.17 |
Total Common Equity | -0.65 | 1.58 | 1.34 | 1.6 | -1.98 | -0.53 |
Minority Interest | - | - | - | - | -0.35 | -0.32 |
Shareholders' Equity | -0.65 | 1.58 | 1.34 | 1.6 | -2.33 | -0.85 |
Total Liabilities & Equity | 0.03 | 2.01 | 1.99 | 1.98 | 2.08 | 4.15 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 0.06 | 0.06 | 0.05 | 0.04 | 0.08 | 3.79 |
Net Cash (Debt) | -0.06 | -0.02 | -0.03 | -0.04 | -0.04 | -3.63 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.32 |
Filing Date Shares Outstanding | 20.21 | 20.21 | 10.44 | 10.44 | 12.1 | 11.85 |
Total Common Shares Outstanding | 20.21 | 20.21 | 10.44 | 10.44 | 12.1 | 11.85 |
Working Capital | -0.65 | -0.39 | -0.58 | -0.32 | -4.29 | -1.62 |
Book Value Per Share | -0.03 | 0.08 | 0.13 | 0.15 | -0.16 | -0.04 |
Tangible Book Value | -0.65 | 1.58 | 1.34 | 1.6 | -1.98 | -0.53 |
Tangible Book Value Per Share | -0.03 | 0.08 | 0.13 | 0.15 | -0.16 | -0.05 |
Machinery | - | - | - | - | - | 0.57 |